Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 5/20 | 0.57 |
| ▸ | POLA1 | P09884 | 1/20 | 0.57 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | INPP5D | Q92835 | 1/20 | 0.54 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | VDR | P11473 | 1/20 | 0.54 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.52 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.52 |
| ▸ | EFNA1 | P20827 | 1/20 | 0.52 |
| ▸ | EPHA2 | P29317 | 1/20 | 0.52 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.52 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.52 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.52 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.52 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.52 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.52 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4740626 | 1.00 | CDC25A (0.57) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL27525051 | 0.93 | CDC25A (0.59) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL27986180 | 0.92 | CYP2D6 (0.56) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL19991441 | 0.91 | CDC25A (0.54) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL4737385 | 0.91 | CDC25A (0.55) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL4736046 | 0.91 | CDC25A (0.55) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL28186318 | 0.90 | CDC25A (0.53) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL4728278 | 0.90 | CYP2D6 (0.55) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL4735035 | 0.89 | CDC25A (0.54) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL4738058 | 0.89 | CDC25A (0.54) | CDC25APOLA1CYP2D6CYP2C19INPP5D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030157158-A1 | Enhanced liposomal thioretinaco ozonide compositions and liposomal carrier | MCCULLY KILMER S (US) | 2003-08-21 | — | — | US | claimed |
| WO-2003057192-A1 | ENHANCED LIPOSOMAL THIORETINACO OZONIDE COMPOSITIONS AND LIPOSOMAL CARRIER | MCCULLY KILMER S (US) | 2003-07-17 | — | — | WO | claimed |
| JP-2200608-A | — | — | None | — | — | JP | disclosed |
| WO-2008131192-A2 | CRYSTALLINE CHOLESTROL AND PREVENTION OF ATHEROSCLEROSIS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2008-10-30 | — | — | WO | disclosed |
| WO-2008077247-A1 | COATINGS FOR IMPLANTABLE MEDICAL DEVICES COMPRISING CHOLESTEROL | MIV THERAPEUTICS INC. (CA) | 2008-07-03 | — | — | WO | disclosed |
| US-6696082-B2 | COMPLEX COMPRISING N-HOMOCYSTEINE THIOLACTONYL RETINAMIDE, COBALAMIN, OZONE, OXYGEN, AND ADENOSINE TRIPHOSPHATE; ANTICARCINGENIC, ANTITUMOR, AND VIRICIDAL AGENTS; ATHEROSCLEROSIS PREVENTION; AGING RESISTANCE | MCCULLY KILMER S (US) | 2004-02-24 | — | — | US | disclosed |
| US-20030157158-A1 | Enhanced liposomal thioretinaco ozonide compositions and liposomal carrier | MCCULLY KILMER S (US) | 2003-08-21 | — | — | US | disclosed |
| WO-2003057192-A1 | ENHANCED LIPOSOMAL THIORETINACO OZONIDE COMPOSITIONS AND LIPOSOMAL CARRIER | MCCULLY KILMER S (US) | 2003-07-17 | — | — | WO | disclosed |
| US-6274118-B1 | INJECTING PATIENT HAVING ENDOCRINE CANCER IN NON-PROSTATIC TISSUE WITH BIOLOGICAL BINDING UNITS WHICH BIND TO PROSTATE SPECIFIC ANTIGEN PRODUCED BY NON-PROSTATIC TISSUE | NORDION INTERNATIONAL INC. (CA) | 2001-08-14 | — | — | US | disclosed |
| WO-1995002424-A1 | LOCALIZATION AND THERAPY OF NON-PROSTATIC ENDOCRINE CANCER WITH AGENTS DIRECTED AGAINST PROSTATE SPECIFIC ANTIGEN | NORDION INTERNATIONAL INC. (CA) | 1995-01-26 | — | — | WO | disclosed |
| JP-H02200608-A | COSMETIC | POLA CHEM IND INC | 1990-08-08 | — | — | JP | disclosed |
| US-4252719-A | REMOVAL OF A TERTIARY HYDROGEN FROM A 5-A-STEROID BY CHLORINATING THE STEROID BEING FIRST ESTERIFIED BY AN IODOARYL-CONTAINING ESTERIFICATION AGENT | RESEARCH CORPORATION (US) | 1981-02-24 | — | — | US | disclosed |